In fact, many reports have demonstrated that there is synergistic inhibitory effect of different drug combinations using BET inhibitors in multiple cancer types, for example, epigenetic inhibitors57, cell cycle inhibitors58, DNA damaging repair inhibitors59, and chemotherapeutic agents60, implying that targeting bromodomain-containing proteins by inhibitors has potential clinical benefits in cancer treatment. Here, DNER is linked to cancer.